We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $29.6M invested in Aptevo Therapeutics in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more capital invested

Capital invested by funds: $15.8M → $29.6M (+$13.8M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SC
1
Sessa Capital
New York
$6.9M
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$4.65M
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.14M
Renaissance Technologies
4
Renaissance Technologies
New York
$1.82M
BlackRock
5
BlackRock
New York
$1.49M
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$1.38M
CL
7
CSS LLC
Illinois
$939K
Millennium Management
8
Millennium Management
New York
$911K
Victory Capital Management
9
Victory Capital Management
Texas
$827K
PM
10
Precept Management
Texas
$806K
FSCM
11
First Sabrepoint Capital Management
Texas
$721K
VF
12
Virtu Financial
New York
$690K
OAM
13
Oxford Asset Management
United Kingdom
$599K
Fidelity Investments
14
Fidelity Investments
Massachusetts
$596K
AA
15
AQR Arbitrage
Connecticut
$562K
Geode Capital Management
16
Geode Capital Management
Massachusetts
$408K
SIM
17
Spark Investment Management
New York
$300K
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$287K
ARTA
19
A.R.T. Advisors
New York
$251K
JP Morgan Chase
20
JP Morgan Chase
New York
$241K
Northern Trust
21
Northern Trust
Illinois
$235K
BCM
22
Bridgeway Capital Management
Texas
$194K
UBS Group
23
UBS Group
Switzerland
$193K
OAC
24
OMERS Administration Corp
Ontario, Canada
$159K
Morgan Stanley
25
Morgan Stanley
New York
$116K